A tipping point may be coming. A crowded marketplace was already pressuring winemakers to cut prices. Now, the drought is pushing up costs.» Read More
Men are growing beards to assert dominance over other men and appeal to women, a report in The Telegraph suggests.
While veterinary groups recommend pain treatment, only about 10 percent of calves are properly medicated, according to Vermont dairy cattle breeder Mark Rodgers. Yet, the change may come sooner than producers expected, as some of the nation's largest food companies, such as General Mills, Nestle and Dunkin' Brands, are asking dairy suppliers to incorporate...
Antarctica may have marked its warmest day ever recorded earlier this week, with a temperature reading of 63.5 F.
WASHINGTON— The small Lego machine inside the White House whirred, and in a moment it was turning the pages of a story book. "We had a brainstorming session," one of the five 6- year-old Girl Scouts replied. The kindergartners and first graders from Tulsa, Oklahoma, were among 35 young science fair winners who came to the White House Monday to showcase breakthroughs...
Biogen will move its Alzheimer's drug quickly into phase 3 studies, jumping over the middle stage, reports CNBC's Meg Tirrell.
Scientists have found a way to create mutant organisms more reliably using a recently developed gene-editing technique, NBC reports.
In drought-stricken California, farmers make more selling water than rice. NBC News reports.
From vaccines to genetically-modified foods, the scientific community is often stuck playing defense. When did science become a dirty word?
March 6- Lower-cost versions of biological drugs, known as biosimilars, are taking aim at some of the world's biggest-selling medicines. Unlike chemical compounds, such as aspirin or statins, these biotech products are made of hormones, antibodies and other proteins. DIFFERENT REGULATORY PATHWAYS Biosimilars are already sold in Europe, Japan and other parts...
Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.
WASHINGTON, Feb 27- A significant majority of Americans say combating climate change is a moral issue that obligates them- and world leaders- to reduce carbon emissions, a Reuters/ IPSOS poll has found. The result of the poll suggests that appeals based on ethics could be key to shifting the debate over climate change in the United States, where those demanding...
Llamas appear to be immune to AIDS and HIV, giving scientists hope for developing a vaccine or treatment. Global Post reports.
A spacewalk to prep the International Space Station for commercial spacecraft was delayed, but plans to reopen the American docks will go on.
A cold snap in Florida may threaten next year's citrus crop, and California growers are fighting for their future.
Wal-Mart will raise its minimum wage for entry level workers, and will give raises to nearly 40 percent of its workforce. CNBC's Kate Rogers has this morning's top headlines.
UMass reversed a controversial policy change and continue to accept Iranian nationals into science and engineering programs, NBC News reports.
The economics surrounding a certain commodity can be a game changer for city officials in the snow belt. And it's sitting on your dinner table.
Marijuana might make brain cells that normally suppress the appetite reverse their behavior and encourage eating, says a new study.
Ron Klain, former U.S. Ebola czar, explains the safety and importance of vaccinating children to protect against measles.
Re/code's Kara Swisher talks to President Obama about STEM, education and bringing the best workers to the US. He also talks about immigration reform as a way to make it easier for companies to bring in talent.